Shares of ImmunoGen dropped 6.14% to $9.17 at 16:16 EST on Tuesday, after four sequential sessions in a row of gains. NASDAQ Composite is falling 0.08% to $13,522.60, following last session’s downward trend, This seems, at the moment, a somewhat negative trend exchanging session today.
ImmunoGen’s last close was $9.77, 18.65% below its 52-week high of $10.88.
ImmunoGen’s sales growth is 27.7% for the present quarter and 30.6% for the next. The company’s growth estimates for the present quarter and the next is a negative 11.8% and a negative 35.7%, respectively.
Year-on-year quarterly revenue growth grew by 91.2%, now sitting on 132.3M for the twelve trailing months.
ImmunoGen’s last day, last week, and last month’s average volatility was 0.72%, 6.98%, and 5.10%, respectively.
ImmunoGen’s last day, last week, and last month’s high and low average amplitude percentage was 7.45%, 11.30%, and 8.15%, respectively.
ImmunoGen’s Stock Yearly Top and Bottom Value
ImmunoGen’s stock is valued at $9.17 at 16:16 EST, way below its 52-week high of $10.88 and way higher than its 52-week low of $1.95.
ImmunoGen’s Moving Average
ImmunoGen’s worth is way above its 50-day moving average of $7.78 and way above its 200-day moving average of $5.75.